A new study out of Oxford University suggests COVID-19 patients could be saved with the help of dexamethasone, an inexpensive and widely used steroid. If the findings bear out, it would be the first drug known to reduce deaths of severely ill COVID-19 patients. Briana Vannozzi asked Rutgers University professor of medicine and infectious diseases Dr. Martin Blaser if it’s the breakthrough we’ve been waiting for. To watch the interview.
Recent Posts
- Researchers Find Medicaid Is Crucial to Access Treatment for Opioid Addiction.
- New Charts for Artery Stiffness Could Flag Heart Risk Long Before Symptoms.
- When It Comes to Breastfeeding, Study Shows Timing Is an Important Consideration.
- A Rutgers Scientist Confronts the Assertive “Bouncer” of the Brain, Seeking Insights into Human Health.
- Nicotine Pouches May Offer Path to Reduced Tobacco Harm.
Categories
- Community (2,341)
- Covid (991)
- CTO Events (6)
- News (2,976)
- Pilots (21)